Children enroll in Pfizer and Moderna trials for those under 12 - The Washington Post
”Investigators are scaling the dosing according to age. In the Moderna trial, some children 6 to 11 years old are starting at adult doses or given less; younger children are starting with lower doses. Pfizer is starting children with a third of a dose and scaling up, and then basing younger children’s doses on older children’s responses. The Pfizer vaccine approved last week for 12-to-15-year-olds is the same dose as for adults, but sometimes lower doses are equally effective in children because their immune systems may be more responsive.“
選擇“Disable on www.wenxuecity.com”
選擇“don't run on pages on this domain”
